ALPS Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-52,273	Closed	-$895K	–	1025
2023 Q1	$895K	Sell	52,273 -1,096	-2%	-$21.5K	0.01%	493
2022 Q4	$1.04M	Buy	53,369 +17,339	+48%	+$319K	0.01%	472
2022 Q3	$575K	Sell	36,030 -3,024	-8%	-$47.2K	0.01%	570
2022 Q2	$537K	Sell	39,054 -27,240	-41%	-$325K	0.01%	569
2022 Q1	$1.05M	Sell	66,294 -8,283	-11%	-$143K	0.01%	307
2021 Q4	$1.63M	Sell	74,577 -3,393	-4%	-$92.6K	0.02%	306
2021 Q3	$2.33M	Sell	77,970 -5,133	-6%	-$187K	0.02%	267
2021 Q2	$3.68M	Sell	83,103 -28,669	-26%	-$1.25M	0.03%	197
2021 Q1	$4.96M	Buy	111,772 +12,019	+12%	+$660K	0.05%	176
2020 Q4	$5.47M	Buy	99,753 +29,372	+42%	+$1.07M	0.06%	170
2020 Q3	$1.61M	Sell	70,381 -4,865	-6%	-$120K	0.02%	261
2020 Q2	$1.57M	Sell	75,246 -23,245	-24%	-$419K	0.02%	259
2020 Q1	$1.37M	Sell	98,491 -2,975	-3%	-$58.9K	0.02%	240
2019 Q4	$2.31M	Buy	+101,466	New	+$1.69M	0.02%	216
2018 Q4	–	Sell	-70,185	Closed	-$1.73M	–	927
2018 Q3	$1.73M	Buy	70,185 +13,008	+23%	+$282K	0.01%	272
2018 Q2	$1.12M	Buy	+57,177	New	+$1.08M	0.01%	314
2017 Q2	–	Sell	-5,792	Closed	-$46K	–	783
2017 Q1	$46K	Sell	5,792 -678	-10%	-$4.56K	﹤0.01%	727
2016 Q4	$158K	Sell	6,470 -2,113	-25%	-$60.3K	﹤0.01%	702
2016 Q3	$325K	Sell	8,583 -697	-8%	-$21.9K	﹤0.01%	640
2016 Q2	$276K	Buy	9,280 +1,855	+25%	+$65.2K	﹤0.01%	586
2016 Q1	$220K	Sell	7,425 -1,273	-15%	-$38.2K	﹤0.01%	600
2015 Q4	$394K	Buy	+8,698	New	+$379K	﹤0.01%	603

Other funds holding RCKT